Pages that link to "Q48682360"
Jump to navigation
Jump to search
The following pages link to Neuroprotection by urokinase plasminogen activator in the hippocampus (Q48682360):
Displaying 13 items.
- Subacute intranasal administration of tissue plasminogen activator promotes neuroplasticity and improves functional recovery following traumatic brain injury in rats (Q28542725) (← links)
- Intraventricular administration of urokinase as a novel therapeutic approach for communicating hydrocephalus. (Q31129029) (← links)
- Urokinase-type plasminogen activator promotes dendritic spine recovery and improves neurological outcome following ischemic stroke (Q34383402) (← links)
- Neurotoxicity of perfluorooctane sulfonate to hippocampal cells in adult mice (Q34575352) (← links)
- Tissue and urokinase plasminogen activators instigate the degeneration of retinal ganglion cells in a mouse model of glaucoma (Q36386411) (← links)
- Urokinase-type plasminogen activator (uPA) and its receptor (uPAR) promote neurorepair in the ischemic brain (Q38626537) (← links)
- Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop (Q39722375) (← links)
- Epileptogenesis after traumatic brain injury in Plau-deficient mice (Q40647101) (← links)
- Long-lived weight-reduced αMUPA mice show higher and longer maternal-dependent postnatal leptin surge (Q47175179) (← links)
- Urokinase-type plasminogen activator modulates mammalian circadian clock phase regulation in tissue-type plasminogen activator knockout mice (Q48140296) (← links)
- Decreased levels of active uPA and KLK8 assessed by [111 In]MICA-401 binding correlate with the seizure burden in an animal model of temporal lobe epilepsy (Q48189431) (← links)
- Interaction of the cell adhesion molecule CHL1 with vitronectin, integrins, and the plasminogen activator inhibitor-2 promotes CHL1-induced neurite outgrowth and neuronal migration. (Q48471416) (← links)
- Attenuation of urokinase activity during experimental ischaemia protects the cerebral barrier from damage through regulation of matrix metalloproteinase-2 and NAD(P)H oxidase. (Q52648658) (← links)